SEARCH

SEARCH BY CITATION

References

  • 1
    Chen, J., Baig, E. and Fish, E. N., Diversity and relatedness among the type I interferons. J. Interferon Cytokine Res. 2004. 24: 687698.
  • 2
    de Weerd, N. A., Samarajiwa, S. A. and Hertzog, P. J., Type I interferon receptors: biochemistry and biological functions. J. Biol. Chem. 2007. 282: 2005320057.
  • 3
    Platanias, L. C., Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 2005. 5: 375386.
  • 4
    Nguyen, K. B., Watford, W. T., Salomon, R., Hofmann, S. R., Pien, G. C., Morinobu, A., Gadina, M. et al., Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 2002. 297: 20632066.
  • 5
    Tanabe, Y., Nishibori, T., Su, L., Arduini, R. M., Baker, D. P. and David, M., Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. J. Immunol. 2005. 174: 609613.
  • 6
    Pestka, S., The interferons: 50 years after their discovery, there is much more to learn. J. Biol. Chem. 2007. 282: 2004720051.
  • 7
    Alsharifi, M., Mullbacher, A. and Regner, M., Interferon type I responses in primary and secondary infections. Immunol. Cell Biol. 2008. 86: 239245.
  • 8
    Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P. et al., Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 2003. 4: 10091015.
  • 9
    Santini, S. M., Di Pucchio, T., Lapenta, C., Parlato, S., Logozzi, M. and Belardelli, F., The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. J. Interferon Cytokine Res. 2002. 22: 10711080.
  • 10
    Le Bon, A., Durand, V., Kamphuis, E., Thompson, C., Bulfone-Paus, S., Rossmann, C., Kalinke, U. et al., Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J. Immunol. 2006. 176: 46824689.
  • 11
    Curtsinger, J. M., Valenzuela, J. O., Agarwal, P., Lins, D. and Mescher, M. F., Type I IFNs provide a third signal to CD8+ T cells to stimulate clonal expansion and differentiation. J. Immunol. 2005. 174: 44654469.
  • 12
    Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J. and Murali-Krishna, K., Type I interferons act directly on CD8+ T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 2005. 202: 637650.
  • 13
    Marrack, P., Kappler, J. and Mitchell, T., Type I interferons keep activated T cells alive. J. Exp. Med. 1999. 189: 521530.
  • 14
    Agarwal, P., Raghavan, A., Nandiwada, S. L., Curtsinger, J. M., Bohjanen, P. R., Mueller, D. L. and Mescher, M. F., Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8+ T cell effector function and memory. J. Immunol. 2009. 183: 16951704.
  • 15
    Kayagaki, N., Yamaguchi, N., Nakayama, M., Eto, H., Okumura, K. and Yagita, H., Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 1999. 189: 14511460.
  • 16
    Hamann, D., Baars, P. A., Rep, M. H., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R. and van Lier, R. A., Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 1997. 186: 14071418.
  • 17
    Einsele, H., Kapp, M. and Grigoleit, G. U., CMV-specific T cell therapy. Blood Cells Mol. Dis. 2008. 40: 7175.
  • 18
    Ji, X., Cheung, R., Cooper, S., Li, Q., Greenberg, H. B. and He, X. S., Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C. Hepatology 2003. 37: 610621.
  • 19
    Waddell, S. J., Popper, S. J., Rubins, K. H., Griffiths, M. J., Brown, P. O., Levin, M. and Relman, D. A., Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS One 5: e9753.
  • 20
    Waldmann, T. A., The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 2006. 6: 595601.
  • 21
    Ramos, H. J., Davis, A. M., Cole, A. G., Schatzle, J. D., Forman, J. and Farrar, J. D., Reciprocal responsiveness to interleukin-12 and interferon-alpha specifies human CD8+ effector versus central memory T-cell fates. Blood 2009. 113: 55165525.
  • 22
    Nutt, S. L., Kallies, A. and Belz, G. T., Blimp-1 connects the intrinsic and extrinsic regulation of T cell homeostasis. J. Clin. Immunol. 2008. 28: 97106.
  • 23
    Mescher, M. F., Curtsinger, J. M., Agarwal, P., Casey, K. A., Gerner, M., Hammerbeck, C. D., Popescu, F. et al., Signals required for programming effector and memory development by CD8+ T cells. Immunol. Rev. 2006. 211: 8192.
  • 24
    Bachmann, M. F., Gallimore, A., Linkert, S., Cerundolo, V., Lanzavecchia, A., Kopf, M. and Viola, A., Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells. J. Exp. Med. 1999. 189: 15211530.
  • 25
    Bahl, K., Kim, S. K., Calcagno, C., Ghersi, D., Puzone, R., Celada, F., Selin, L. K. et al., IFN-induced attrition of CD8+ T cells in the presence or absence of cognate antigen during the early stages of viral infections. J. Immunol. 2006. 176: 42844295.
  • 26
    Dondi, E., Rogge, L., Lutfalla, G., Uze, G. and Pellegrini, S., Down-modulation of responses to type I IFN upon T cell activation. J. Immunol. 2003. 170: 749756.
  • 27
    Gimeno, R., Lee, C. K., Schindler, C. and Levy, D. E., Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes. Mol. Cell Biol. 2005. 25: 54565465.
  • 28
    Gil, M. P., Salomon, R., Louten, J. and Biron, C. A., Modulation of STAT1 protein levels: a mechanism shaping CD8+ T-cell responses in vivo. Blood 2006. 107: 987993.
  • 29
    Kaser, A., Nagata, S. and Tilg, H., Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression. Cytokine 1999. 11: 736743.
  • 30
    Lombardi, G., Dunne, P. J., Scheel-Toellner, D., Sanyal, T., Pilling, D., Taams, L. S., Life, P. et al., Type 1 IFN maintains the survival of anergic CD4+ T cells. J. Immunol. 2000. 165: 37823789.
  • 31
    McNally, J. M., Zarozinski, C. C., Lin, M. Y., Brehm, M. A., Chen, H. D. and Welsh, R. M., Attrition of bystander CD8+ T cells during virus-induced T-cell and interferon responses. J. Virol. 2001. 75: 59655976.
  • 32
    Pilling, D., Akbar, A. N., Girdlestone, J., Orteu, C. H., Borthwick, N. J., Amft, N., Scheel-Toellner, D. et al., Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur. J. Immunol. 1999. 29: 10411050.
  • 33
    Scheel-Toellner, D., Pilling, D., Akbar, A. N., Hardie, D., Lombardi, G., Salmon, M. and Lord, J. M., Inhibition of T cell apoptosis by IFN-beta rapidly reverses nuclear translocation of protein kinase C-delta. Eur. J. Immunol. 1999. 29: 26032612.
  • 34
    Gombert, W., Borthwick, N. J., Wallace, D. L., Hyde, H., Bofill, M., Pilling, D., Beverley, P. C. et al., Fibroblasts prevent apoptosis of IL-2-deprived T cells without inducing proliferation: a selective effect on Bcl-XL expression. Immunology 1996. 89: 397404.